2012 ©
             Publication
Journal Publication
Research Title Nrf2 silencing confers chemosensitizing effect on cholangiocarcinoma cells via repression of antioxidant genes and induction of cell cycle arrest 
Date of Distribution 3 February 2016 
Conference
     Title of the Conference The 13th Asia Pacific Federation of Pharmacologist (APFP) Meeting 
     Organiser The Pharmacological and Therapeutic Society of Thailand, The Asia Pacific Federation of Pharmacologists  
     Conference Place The Berkeley Hotel Pratunam 
     Province/State Bangkok, Thailand 
     Conference Date 1 February 2016 
     To 3 February 2016 
Proceeding Paper
     Volume 2559 
     Issue 13 
     Page 98 
     Editors/edition/publisher APFP 2016 
     Abstract The nuclear factor erythroid 2-like 2 (Nrf2) is a transcription factor which plays important role in cellular protection from various toxic and carcinogenic agents. Induction of Nrf2 in cancer cells provides chemoresistance by upregulation of the expression of a number of antioxidant genes and thereby, rendering cancer resistance and growth. Cholangiocarcinoma (CCA) is a very aggressive and resistance malignancy and is a major health problem in Thailand. The aim of study was to determine the effect of Nrf2 inhibition on the sensitivity to chemotherapy in cancer cells. CCA cell lines, KKU-M156, KKU-M214, KKU-M213 and KKU-100 were used in the study. Nrf2 expression was suppressed by siRNA and sensitivity to anticancer drugs, gemcitabine (Gem), cisplatin (Cis) and 5-fluorouracil (5-FU) was analyzed by acridine-orange/ethidium bromide. The result was found that the cytotoxicity in Nrf2-knockdown cells was highly enhanced. The exposure to Gem, Cis, 5-FU, and tBHQ, a potent Nrf2 inducer, induced mRNA expression of Nrf2 and antioxidant genes, including NQO1, HO-1, GCLC, and GSTP1 and expression of protein NQO1, HO-1, GCLC, and Trx in KKU-100 and KKU-M156 cells. Knockdown of Nrf2 suppressed the Cis-induced expression of Nrf2 and Nrf2-regulated genes. In flow cytometric analysis, inhibition of Nrf2 in KKU-M156 altered cell cycle progression by blocking the G0/G1 to S transition. Treatment with Cis induced DNA damage and caused an increase of cells at the S phase. Nrf2 knockdown cells treated with Cis resulted cells accumulated in the G0/G1phase. Suppression of Nrf2 signaling confers chemosensitizing effect on cholangiocarcinoma cells via repression of antioxidant genes and induction cell cycle arrest. Targeting on Nrf2 may be a novel strategy in improve efficacy in chemotherapy of CCA. This work was supported by the Office of the Higher Education Commission through the Health Cluster, SHeP-GMS of Khon Kaen University, Grants in-aid from Khon Kaen University and a scholarship from the Royal Golden Jubilee Ph.D. Programme. 
Author
547070027-6 Miss PAPAVEE SAMATIWAT [Main Author]
Medicine Doctoral Degree

Peer Review Status มีผู้ประเมินอิสระ 
Level of Conference นานาชาติ 
Type of Proceeding Abstract 
Type of Presentation Poster 
Part of thesis true 
Presentation awarding true 
     Award Title The Best Poster Presentation Award 
     Type of award รางวัลด้านวิชาการ วิชาชีพ 
     Organiser The Pharmacological and Therapeutic Society of Thailand, The Asia Pacific Federation of Pharmacologists  
     Date of awarding 3 กุมภาพันธ์ 2559 
Attach file
Citation 0

<
forum